FDA Product Code HQC: Unit, Phacofragmentation
Cataract surgery is the most commonly performed ophthalmic procedure worldwide. FDA product code HQC covers phacofragmentation units used to emulsify and aspirate the cataractous lens.
These systems use ultrasonic vibration at the tip of a needle to fragment the lens nucleus into small pieces that are simultaneously aspirated, allowing removal of the opaque lens through a small incision before intraocular lens implantation.
HQC devices are Class II medical devices, regulated under 21 CFR 886.4670 and reviewed by the FDA Ophthalmic panel.
Leading manufacturers include Carl Zeiss Meditec Cataract Technology, Inc., Carl Zeiss Meditec, AG and Johnson & Johnson Surgical Vision, Inc..
FDA 510(k) Cleared Unit, Phacofragmentation Devices (Product Code HQC)
About Product Code HQC - Regulatory Context
510(k) Submission Activity
316 total 510(k) submissions under product code HQC since 1977, with 316 receiving FDA clearance (average review time: 114 days).
Submission volume has remained relatively stable over the observed period, with 6 submissions in the last 24 months.
FDA 510(k) Review Time - HQC Product Code
Recent submissions under HQC have taken an average of 216 days to reach a decision - up from 112 days historically. Manufacturers should account for longer review timelines in current project planning.
HQC devices are reviewed by the Ophthalmic panel. Browse all Ophthalmic devices →